Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 18Active not recruiting 13Completed 5Terminated 3Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Gemcitabine 14Androgen Antagonists 13Specimen Handling 12Radiotherapy 12Magnetic Resonance Spectroscopy 10Radiosurgery 9pembrolizumab 8Nivolumab 8darolutamide 7Drug Therapy 7toripalimab 6Docetaxel 6Cystectomy 6Abiraterone Acetate 6enzalutamide 5apalutamide 5Pluvicto 5Mitomycin 5Cisplatin 5disitamab vedotin 4Ipilimumab 4Cyclophosphamide 4Biopsy 4Axitinib 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3cabozantinib 3abiraterone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × X-Rays × Genitourinary × Clear all
NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
24 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡